Human Papilloma Virus Clinical Trials

164 clinical trials for Human Papilloma Virus across international registries, including 31 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• PopSci CHW4CervixHealth — RECRUITING · NA
• Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV — RECRUITING · PHASE2
• Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance. — RECRUITING · NA
• Merck IIT: RRP Pembro and Lenvatinib — RECRUITING · PHASE2
• Leveraging Project ECHO for Improved Cervical Cancer Screening in Ethiopia — RECRUITING · NA
• Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) — RECRUITING · PHASE2
• HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV — RECRUITING · PHASE1
• Unidos Contra el VPH — RECRUITING · NA
• HPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks — RECRUITING
• Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery — RECRUITING · PHASE1
• Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris) — RECRUITING · PHASE3
• A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer — RECRUITING · PHASE2
• Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma — RECRUITING
• Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy — RECRUITING
• A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV — RECRUITING · PHASE4
• Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective — RECRUITING
• Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2) — RECRUITING · PHASE3
• Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine — RECRUITING · NA
• Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling — RECRUITING
• Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts — RECRUITING · PHASE2
• Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer — RECRUITING · PHASE3
• Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia — RECRUITING
• HPV-based Screening Among Women 23-29 Years of Age — RECRUITING · NA
• High Resolution Anuscopy Study — RECRUITING
• Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections. — RECRUITING · PHASE4
• Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples — RECRUITING · NA
• Impact of Human Papillomavirus Carriage on IVF/ICSI Results (HPV AMP) — RECRUITING
• Anal Follow-up of Patients With a Gynecological History of High-grade Lesion and More Induced HPV — RECRUITING
• MOLECULAR RESIDUAL DISEASE INTERCEPTION IN LOCOREGIONALLY-ADVANCED HIGH RISK HPV+ AND HPV- HNSCC (MERIDIAN) — RECRUITING
• A PHASE III RANDOMIZED, INTERNATIONAL, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL TO STUDY THE TOLERABILITY AND IMMUNOGENICITY OF V503, A MULTIVALENT HUMAN PAPILLOMAVIRUS (HPV) L1 VIRUS-LIKE PARTICLE (VLP) VACCINE, GIVEN TO FEMALES 12-26 YEARS OF AGE WHO HAVE PREVIOUSLY RECEIVED GARDASIL — RECRUITING · PHASE3
• A PHASE III CLINICAL TRIAL TO STUDY THE TOLERABILITY AND IMMUNOGENICITY OF A 2-DOSE REGIMEN OF V503, A MULTIVALENT HUMAN PAPILLOMAVIRUS (HPV) L1 VIRUS-LIKE PARTICLE (VLP) VACCINE, ADMINISTERED IN PREADOLESCENTS AND ADOLESCENTS (9 TO 14 YEAR OLDS) WITH A COMPARISON TO YOUNG WOMEN (16 TO 24 YEAR OLDS) — RECRUITING · PHASE3
• Developing and Implementing HPV SCREENED — NOT_YET_RECRUITING · NA
• Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic — COMPLETED · PHASE2
• Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. — NOT_YET_RECRUITING · PHASE4
• Hashtag HPV: HPV Vaccine Twitter Education Program — COMPLETED · NA
• A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV) — NOT_YET_RECRUITING · PHASE2
• TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck — COMPLETED · NA
• Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old — ACTIVE_NOT_RECRUITING · PHASE1
• Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3) — NOT_YET_RECRUITING · PHASE3
• Impact of Financial Incentives — ACTIVE_NOT_RECRUITING · NA
• A clinical study of the V540C vaccine in healthy adults (V540C-003) — TERMINATED · PHASE1
• Blood Biomarkers Based Screening for HPV-driven OPC — NOT_YET_RECRUITING · NA
• Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study — ACTIVE_NOT_RECRUITING · NA
• A clinical study of the V540A vaccine in healthy adults (V540A-001) — OTHER · PHASE1
• Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV — NOT_YET_RECRUITING · PHASE1
• A Proximity-incentive Strategy for Cervical Cancer Screening — COMPLETED · NA
• TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• HPV Testing as a Prevention of Cervical Dysplasia and Cancer Before Planned Subtotal Hysterectomy — NOT_YET_RECRUITING
• Impact of Standing Orders Optimization — ACTIVE_NOT_RECRUITING · NA
• Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department — TERMINATED

Refine this search